Of all the treatments available at Dr. J Anti-Aging Clinic, the MENZ Tox Shot™ is the one that gets the most raised eyebrows when I explain it. Botox. In the penis. For erectile dysfunction.
I understand the reaction. Botulinum toxin has become so synonymous with cosmetic wrinkle treatment that its application in men’s sexual health sounds like a joke at first. It isn’t. There’s a coherent physiological rationale, a growing body of randomized controlled trial data, and a 2025 meta-analysis confirming meaningful clinical response in a real patient population. Let me walk through what the science actually says.
The Mechanism: Why Botulinum Toxin Makes Physiological Sense for ED
The erection process depends on a sequence of vascular events. Sexual arousal triggers nitric oxide release, which relaxes the smooth muscle of penile arteries and the corpus cavernosum, allowing blood to flow in and fill the erectile chambers. In vasculogenic erectile dysfunction, the smooth muscle of penile arteries is abnormally contracted chronically elevated sympathetic tone and impaired nitric oxide signaling keep the vasculature constricted even when arousal occurs.
Botulinum toxin type A (BoNT-A) inhibits the release of acetylcholine and norepinephrine from autonomic nerve terminals. Injected into the corpus cavernosum in a small, precisely calibrated dose, it reduces the sympathetic-mediated smooth muscle contraction that opposes erection effectively lowering vascular resistance and allowing blood flow that the diseased vasculature was suppressing.
This is a different mechanism from acoustic wave therapy (which builds new blood vessels) and PRP (which repairs tissue). Botulinum toxin is a functional release: it works with the vascular architecture that exists by removing the neurogenic barrier to blood flow.
The Clinical Evidence
El-Shaer 2021 The Landmark RCT
The most significant study in this field is El-Shaer et al., published in Andrology in 2021. This was a prospective, randomized, double-blind, placebo-controlled trial involving 176 men with vasculogenic ED who had not responded to PDE5 inhibitors (Viagra or Cialis) or Trimix injections. This is a challenging population these are men for whom standard treatments have already failed.
Patients were randomized to Botox 100 units, Botox 50 units, or saline placebo and followed for 6 months. Both treatment groups showed statistically significant improvements in IIEF score, Erection Hardness Score, and peak systolic velocity on penile Doppler ultrasound compared to placebo. The 100-unit group showed the strongest response. The effect lasted the full 6-month follow-up period.
El-Shaer et al., Andrology, 2021. PMID: 33784020
Abdelrahman 2022 and Giuliano 2022 Replication
The El-Shaer results were replicated in subsequent studies. Abdelrahman et al. (Andrology, 2022) conducted a randomized controlled trial of botulinum neurotoxin in ED refractory to PDE5 inhibitors, finding significant improvements in IIEF and EHS versus placebo. Giuliano et al. (2022) followed 123 men with ED insufficient to standard pharmacological therapy in a single-center study a meaningful proportion showed clinically significant improvement on validated outcome measures.
Abdelrahman et al., 2022. PMID: 34618409 | Giuliano et al., 2022. PMID: 34937674
Pang 2025 The Most Comprehensive Synthesis
The most recent and comprehensive evidence synthesis is Pang et al. (2025), a PRISMA 2020-compliant systematic review and meta-analysis of 6 studies meeting inclusion criteria (2 RCTs, 4 retrospective). The conclusion: at least 40% of patients with vasculogenic ED who have not responded to standard pharmacological treatment show meaningful clinical response to intracavernosal botulinum toxin. That’s a clinically significant response rate in a population that has already failed conventional therapy.
Pang et al., 2025. PMID: 40330908
The Honest Limitations
⚠️ EVIDENCE NOTE:
Intracavernosal botulinum toxin for ED is an off-label use of the medication. It is not FDA-approved for this indication. The evidence base, while promising, consists of a limited number of RCTs with relatively small sample sizes. Most published studies follow patients for 6 months; long-term durability data beyond that is limited. Effects are expected to wane as botulinum toxin degrades, likely requiring repeat injections every 6–9 months. Dr. J discusses these limitations candidly at consultation.
Where MENZ Tox Shot™ Fits in the Clinical Picture
The MENZ Tox Shot™ is positioned at Dr. J Anti-Aging Clinic primarily as a treatment for men with vasculogenic ED who have not responded adequately to PDE5 inhibitors. It is also used as a component of the multi-modal regenerative protocol combined with MENZ Wave® (which builds new blood vessels) and MENZ Shot™ (which delivers growth factors for tissue repair) providing a third complementary mechanism that addresses smooth muscle tone alongside vascular regeneration.
- Dr. J:
What makes botulinum toxin interesting to me as a physician isn’t that it’s novel it’s that it works through a mechanism that none of the other tools in our kit address. You can rebuild blood vessels and repair tissue, but if sympathetic overactivation keeps the vasculature clamped, you’re still leaving something on the table. This is the treatment that addresses that piece.
For Men in Central Florida
Dr. J Anti-Aging Clinic serves men across the Orlando region and Central Florida Dr. Phillips, Winter Park, Kissimmee, Sanford, Lake Mary, Tampa, Daytona Beach, and beyond. For men who have been told that the remaining option after pill failure is a surgical implant, the MENZ Tox Shot™ individually or as part of a comprehensive protocol represents a legitimate, evidence-backed step worth knowing about.
▸ READY TO TALK TO DR. J?
Curious whether the MENZ Tox Shot™ is appropriate for your situation? Book a confidential consultation at Dr. J Anti-Aging Clinic. Dr. J will review the evidence, your clinical history, and give you an honest recommendation.
Call/Text: (407) 972-1197 | drjantiagingclinic.com